House Dust Mite Allergy Evidence-Based Management-Separating Truth from Fiction Webinar
Patients with house dust mite allergy and asthma comprise a major number of patients cared for by the allergist. This activity will review the latest published data on house dust mite management and break many of the myths of “what works best” for our patients.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1 AMA PRA Category I Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement
This activity was supported by an independent educational grant from ALK-Abelló, Inc.
Target Audience
Allergists, allied health and other allergy practitioners.
Learning Objectives
- Describe how effective indoor dust mite reduction is in improving allergy and asthma control
- Summarize the efficacy and value of pharmacologic agents in decreasing symptoms related to house dust mites
- Compare subcutaneous to sublingual tablet immunotherapy in relief of house dust mite allergy and asthma from the latest published data
- Be able to employ shared decision making for house dust mite immunotherapy your practice setting
Eli Meltzer, MD, FACAAI
ALK: Consultant/Speaker Honorarium, Consulting fee
AstraZeneca: Consultant; Consulting fee
Boehringer-Ingelheim: Consultant; Consulting fee
GlaxoSmithKline: Consultant; Consulting fee
Glenmark: Consultant/Speaker; Consulting Fee, Honorarium
GossamerBio: Consultant; Consulting Fee
Merck: Consultant; Consulting Fee
Mylan: Consultant; Consulting Fee
Regeneron/Sanofi: Consultant, Speaker; Consulting Fee, Honorarium
John Oppenheimer, MD, FACAAI
Teva: Consultant; Consulting fee
DBV Technologies: Consultant; Consulting fee
GlaxoSmithKline: Consultant; Consulting fee
MedImmune: Adjudication; Consulting fee
Sanofi: Consultant; Consulting fee
Up to Date: Reviewer; Honorarium
Medscape: Senior Editor; Honorarium
Michael Blaiss, MD, FACAAI
ALK: Consultant; Consulting fee
Boston Scientific: Consultant; Consulting fee
Pfizer: Consultant; Consulting fee
PMD Healthcare: Consultant; Consulting fee
RX Bands: Consultant; Consulting fee
Stallergenes: Consultant; Consulting fee
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance